107 related articles for article (PubMed ID: 16925158)
1. The time is now.
Gottehrer NR; Berglund SE
Dent Today; 2006 Aug; 25(8):12. PubMed ID: 16925158
[No Abstract] [Full Text] [Related]
2. Healthy living and risk of major chronic diseases in an older population.
Gopinath B; Rochtchina E; Flood VM; Mitchell P
Arch Intern Med; 2010 Jan; 170(2):208-9. PubMed ID: 20101018
[No Abstract] [Full Text] [Related]
3. Tapping into the "real" fountain of youth.
Johns Hopkins Med Lett Health After 50; 2001 Aug; 13(6):4-5, 7. PubMed ID: 14723197
[No Abstract] [Full Text] [Related]
4. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
5. A resolution for community health.
Fan N
Del Med J; 2014 Jan; 86(1):9-10. PubMed ID: 24716384
[No Abstract] [Full Text] [Related]
6. [What is established in exercise therapy?].
Bühring M
Internist (Berl); 1987 Jan; 28(1):65-78. PubMed ID: 3553057
[No Abstract] [Full Text] [Related]
7. [Pioglitazone protects the type-2-diabetes patient from myocardial infarction and stroke].
MMW Fortschr Med; 2007 Aug; 149(31-32):52-3. PubMed ID: 17849787
[No Abstract] [Full Text] [Related]
8. [Epidemiology of the hypertensive heart].
Middeke M
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S253-6. PubMed ID: 19085801
[No Abstract] [Full Text] [Related]
9. [Treating essential hypertension. Are beta blockers still first choice?].
Rahn KH
MMW Fortschr Med; 2007 May; 149(18):43-5. PubMed ID: 17672414
[No Abstract] [Full Text] [Related]
10. Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia.
Gangaidzo IT
Cent Afr J Med; 2005; 51(11-12):125-6. PubMed ID: 17447346
[No Abstract] [Full Text] [Related]
11. Tissue ACE inhibitors for secondary prevention of cardiovascular disease in patients with preserved left ventricular function: a pooled meta-analysis of randomized placebo-controlled trials.
Saha SA; Molnar J; Arora RR
J Cardiovasc Pharmacol Ther; 2007 Sep; 12(3):192-204. PubMed ID: 17875946
[TBL] [Abstract][Full Text] [Related]
12. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study.
Carrington M; Stewart S
Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072
[TBL] [Abstract][Full Text] [Related]
13. The protective effect of risk factors against stroke severity.
Steiner I; Gotkine M; Wirguin I
J Neurol Sci; 2008 Apr; 267(1-2):187-8. PubMed ID: 18068188
[No Abstract] [Full Text] [Related]
14. I've read that, because I have type 2 diabetes, I should take a statin even though my cholesterol levels are normal. Is this true?
Johns Hopkins Med Lett Health After 50; 2005 May; 17(3):8. PubMed ID: 15841555
[No Abstract] [Full Text] [Related]
15. The burden of hyperlipidaemia and diabetes in cardiovascular diseases.
Merkler M; Reiner Z
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():1-3. PubMed ID: 18001311
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
[TBL] [Abstract][Full Text] [Related]
17. Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS).
Neil HA; DeMicco DA; Luo D; Betteridge DJ; Colhoun HM; Durrington PN; Livingstone SJ; Fuller JH; Hitman GA;
Diabetes Care; 2006 Nov; 29(11):2378-84. PubMed ID: 17065671
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin for cardiovascular prevention: too many uncertainties.
Prescrire Int; 2009 Aug; 18(102):176. PubMed ID: 19746571
[TBL] [Abstract][Full Text] [Related]
19. Grand challenges in chronic non-communicable diseases.
Daar AS; Singer PA; Persad DL; Pramming SK; Matthews DR; Beaglehole R; Bernstein A; Borysiewicz LK; Colagiuri S; Ganguly N; Glass RI; Finegood DT; Koplan J; Nabel EG; Sarna G; Sarrafzadegan N; Smith R; Yach D; Bell J
Nature; 2007 Nov; 450(7169):494-6. PubMed ID: 18033288
[No Abstract] [Full Text] [Related]
20. Clopidogrel for preventing cardiovascular events.
Stulman J; McGinn T; Korenstein D
Mt Sinai J Med; 2009 Apr; 76(2):194-7. PubMed ID: 19306382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
